Organic Active Ingredients TRIZ Cases

Determines coating mass via particle surface area measurements to resolve batch-to-batch release profile inconsistencies.

Nucleotide-conjugated metallic nanoclusters penetrate biofilms and eradicate antibiotic-tolerant persister cells.

A fungal and vegetal oligosaccharide blend modulates immune responses through selective cell stimulation.

Pyridinyl sulfonamide derivatives improve AOC3 inhibition efficacy while reducing adverse effects from lack of selectivity.

Suspended nanodiamonds act as catalysts to reduce healing time and alleviate inflammatory symptoms while minimizing side effects.

Thienopyrimidinone compounds lower mutant huntingtin protein concentrations to address underlying disease mechanisms in Huntington's therapy development.

Combines WDR5 and PD-1 inhibitors to overcome tumor resistance and improve durable clinical response rates.

A 5,5'-(sulfonyldimethylene)diuracil compound modulates Shn3 activity to regulate osteoblast function.

Microparticles loaded with immunomodulatory agents induce regulatory T cells, suppressing inflammation without steroid-induced glaucoma.

A recombinant lentiviral vector delivers siRNA to silence IL-6 expression in engineered T cells.

A pharmaceutical composition combining an indolizine derivative with a cyclic dinucleotide to activate the cGAS-STING pathway.

Formula I compounds inhibit PRMT5 enzymatic activity, resolving toxicity trade-offs via parameter changes and local quality modifications.

A block copolymer with thiol-binding groups attaches to immune cells and releases drugs at acidic pH levels.

Process eliminates costly chiral separation by establishing purity early, reducing production costs while maintaining high yields.

Transforming growth factor-beta 2 induces regulatory T cells to prevent allograft rejection while reducing infectious disease risks from systemic suppression.

Segmented dosage forms with pH-sensitive coatings and gelling agents ensure consistent enterokine release in the jejunum despite gastric variability.

Polypropylene sulfide microparticles transition from hydrophobic to hydrophilic upon reactive oxygen species exposure.

Extended-release calcifediol maintains serum 25-hydroxyvitamin D above 50 ng/mL, reducing PTH by 30% without adverse calcium changes.

Queuine compounds stabilize mitochondrial function to prevent neuronal death and reduce L-DOPA side-effects in Parkinson's disease treatment.

Magnetic-guided metallic nanoparticles increase thermal conductivity to create durable lesions while preventing unintended tissue injury.

C2'epiAmB epimer modifies C2' hydroxyl stereochemistry to absorb ergosterol while rejecting cholesterol, resolving Amphotericin B toxicity.

Modified tumor-derived exosomes lacking miR-424 enhance anti-tumor immune responses against nonimmunogenic colorectal cancer.

Ultrasonic waves assist crystallization of (6S)-5-methyltetrahydrofolate calcium salt to produce stable crystal form C.

Pyridinyl and pyrazinyl indolsulfonamide compounds act as negative modulators of the GPR17 receptor.

Pteridine dione compounds inhibit monocarboxylate transporters to disrupt tumor cell metabolism while avoiding off-target effects on normal cells.

A pharmaceutical composition uses a hydrophilic base and hydrogel-forming polymer to control active ingredient release rates.

A multi-layered extended release matrix formulation utilizes high molecular weight polyethylene oxide to achieve zero-order drug delivery.

A 2-pentanone receptor opens ligand-gated cation channels to increase intracellular calcium concentrations.

Spray dried cohesive composite particles blended with carrier particles enhance solubility and aerodynamic performance.

Transdermal ibuprofen gel employs penetration enhancers and solvents to overcome slow skin absorption rates.

N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide targets delta opioid receptors.

SOCS1-KIR peptide mimetics inhibit CD4+ T cell activation and IFNγ signaling to treat autoimmune conditions.

Intranasal betahistine formulation bypasses hepatic first-pass metabolism via nasal mucosa absorption, increasing bioavailability and therapeutic duration.

Sulfur substitution in the sugar ring creates a thionucleoside derivative that bypasses resistance mechanisms to restore gemcitabine efficacy.

Mutant beta-lactamase enzymes hydrolyze excess antibiotics in the gastrointestinal tract, preserving microbiome balance during systemic therapy.

Structural modifications to lincosamides resolve the contradiction between high antimicrobial activity and adverse effects on gut flora.

Analyzing sex hormone concentrations predicts severe respiratory complications, enabling timely aromatase inhibitor treatment.

Segmented synthesis with silyl protecting groups yields crystalline SGLT2 inhibitors, eliminating solvent impurities and protection steps for higher efficiency.

Amphiphilic lipid vesicles encapsulate clove extracts to resolve poor solubility and stability, reducing respiratory inflammation.

Hordenine targets the TLR4/NF-kB/MAPK axis to inhibit PRL and ACTH expression, offering an alternative for drug-resistant prolactinoma cases.

HTCC and HA microgels concentrate drug solutions to increase loading, reducing waste from low-efficiency immersion methods.

Mannooligosaccharides inhibit lipid and sugar absorption in the intestine.

Substituted morpholines enhance calcium sensing receptor sensitivity to lower plasma parathyroid hormone levels in hyperparathyroidism.

Segmented ALK-5 inhibitors resolve limited treatment effectiveness by blocking tumor growth and immune evasion through selective TGFβ pathway modulation.

pH-sensitive carbon nanoparticles exploit acidic tumor environments to trigger structural transformation, enabling targeted drug release at cancer sites.

A self-emulsifying formulation containing oil, surfactant, and structurant spontaneously forms nanoemulsions in aqueous environments.

Selective MMP-9 and MMP-12 inhibitors suppress edema and neuropathic pain while preventing functional decline after spinal cord injury.